Fundraising FoxNeuro-Kinesis
Inglewood, US · Delaware corporation
Find your way into Neuro-Kinesis
Sign up to see every warm intro you have to Neuro-Kinesis
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Neuro-Kinesis team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Neuro-Kinesis develops biosensor-integrated surgical instruments that deliver real-time biological feedback to surgeons during procedures. The company focuses on catheter-based imaging tools and neurosurgical retractors designed to improve procedural outcomes in cardiac mapping, organ visualization, and brain surgery.
Founders & leadership
JS
Josh ShacharBoard Chairman, Chief Executive Officer and Chief Technology Officer
CB
CHRISTOPHER BISSELLCHIEF FINANCIAL OFFICER
FA
Frank AdellDirector, President and CEO
Board
DT
Dr. Thomas Chen, MD, PhDBoard director
RK
Roger KornbergChairman of the Science Advisory Board
TC
Thomas ChenMD, PhD, Director
EA
Eustaquio AbayMD, FACS, Director
Reported raises · per SEC filings
Form D private placements$551K disclosed across 4 rounds · 2020–2026
▶$51KraisedApr 2026 · 5 investors · BiotechnologyRule 506(b)
▶$51KraisedApr 2026 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Eli GangExecutive Officer, Director
- Dr. Thomas Chen, MD, PhDDirector
- Josh ShacharExecutive Officer, Director
- CHRISTOPHER BISSELLExecutive Officer
- Offering amount
- $2M
- Amount sold
- $51K
- Minimum investment
- $10K
- First sale
- Apr 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$400KraisedJul 2021 · 1 investors · BiotechnologyRule 506(b)
▶$400KraisedJul 2021 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Dr. Thomas Chen, MD, PhDDirector
- Eli GangExecutive Officer, Director
- Josh ShacharExecutive Officer, Director
- Frank AdellExecutive Officer, Director
- Offering amount
- $400K
- Amount sold
- $400K
- Minimum investment
- $400K
- First sale
- Jun 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$50KraisedJun 2020 · 1 investors · BiotechnologyRule 506(b)
▶$50KraisedJun 2020 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Frank AdellExecutive Officer, Director
- Dr. Thomas Chen, MD, PhDExecutive Officer, Director
- Josh ShacharExecutive Officer
- Eli GangExecutive Officer, Director
- Christopher BissellExecutive Officer
- Offering amount
- $1M
- Amount sold
- $50K
- Minimum investment
- $50K
- First sale
- Jun 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$50KraisedJun 2020 · 3 investors · BiotechnologyRule 506(b)
▶$50KraisedJun 2020 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Dr. Thomas Chen, MD, PhDExecutive Officer, Director
- Josh ShacharExecutive Officer
- Frank AdellExecutive Officer, Director
- Eli GangExecutive Officer, Director
- Christopher BissellExecutive Officer
- Offering amount
- $5M
- Amount sold
- $50K
- Minimum investment
- $30K
- First sale
- Jun 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 3
MediaroomMediaRoom is a PR Newswire product that builds branded, fully-hosted online newsrooms for organizations to publish press releases, media coverage, images and videos in one place for journalists, investors and other audiences. It offers custom microsite design, automatic press release posting, social media integration, a content management portal, and SOC 2-compliant hosting with analytics.
ToperaAbbott's Lingo Glucose System is a continuous glucose monitoring device for non-insulin users aged 18+, designed to track glucose levels and support metabolic health decisions.
HealthcarediveHealthcare Dive is a business news publication covering the healthcare industry, reporting on topics such as health IT, policy and regulation, insurance, digital health, payer-provider partnerships, and value-based care. It publishes newsletters and a website aimed at healthcare industry decision makers and is operated by Informa TechTarget.
Companies working in the same space as Neuro-Kinesis.
Frequently asked questions
- What does Neuro-Kinesis do?
- Neuro-Kinesis develops biosensor-integrated surgical instruments that deliver real-time biological feedback to surgeons during procedures. The company focuses on catheter-based imaging tools and neurosurgical retractors designed to improve procedural outcomes in cardiac mapping, organ visualization, and brain surgery.
- How much funding has Neuro-Kinesis raised?
- Neuro-Kinesis has disclosed $551K raised across 4 rounds.
- Where is Neuro-Kinesis headquartered?
- Neuro-Kinesis is headquartered in Inglewood, US.